Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 96 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 7388089

    Anti-arthropod vector vaccines method of selecting and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted
  2. US 7381744

    Method of treating osteoporosis comprising vacuolar-type (H+)-ATPase-inhibiting compounds

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 3, 2008 · Expires May 29, 2028

    granted
  3. US 7381405

    Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 3, 2008 · Expires May 29, 2028

    granted
  4. US 7378257

    Bacterial superantigen vaccines

    The United States of America as represented by the Secretary of the Army · Granted May 27, 2008 · Expires May 22, 2028

    granted
  5. US 7378276

    Method of inducing memory B cell development and terminal differentiation

    The United States of America, as represented by the Department of Health and Human Services · Granted May 27, 2008 · Expires May 22, 2028

    granted
  6. US 7378093

    Broadly cross-reactive neutralizing antibodies against Human Immunodeficiency Virus selected by Env-CD4-co-receptor complexes

    The United States of America, as represented by the Department of Health and Human Services · Granted May 27, 2008 · Expires May 22, 2028

    granted
  7. US 7378097

    Use of penetration enhancers and barrier disruption methods to enhance the immune response of antigen and adjuvant

    The United States of America as represented by the Secretary of the Army · Granted May 27, 2008 · Expires May 22, 2028

    granted
  8. US 7378277

    Methods and compositions for transforming dendritic cells and activating T cells

    The United States of America, as represented by the Department of Health and Human Services · Granted May 27, 2008 · Expires May 22, 2028

    granted
  9. US 7378403

    Akt inhibitors, pharmaceutical compositions, and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted May 27, 2008 · Expires May 22, 2028

    granted
  10. US 7375079

    Previns as specific inhibitors and therapeutic agents for botulinum toxin B and tetanus neurotoxins

    The United States of America as represented by the Secretary of the Army · Granted May 20, 2008 · Expires May 15, 2028

    granted
  11. US 7374931

    Vaccine against staphylococcus intoxication

    The United States of America as represented by the Secretary of the Army · Granted May 20, 2008 · Expires May 15, 2028

    granted
  12. US 7374756

    Specific binding agents for KSHV vIL-6 that neutralize a biological activity

    The United States of America, as represented by the Department of Health and Human Services · Granted May 20, 2008 · Expires May 15, 2028

    granted
  13. US 7374872

    CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection

    The United States of America, as represented by the Department of Health and Human Services · Granted May 20, 2008 · Expires May 15, 2028

    granted
  14. US 7375185

    Cardiac myosin light chain kinase polypeptide, encoding nucleic acid, and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted May 20, 2008 · Expires May 15, 2028

    granted
  15. US 7371392

    Cd40 ligand adjuvant for respiratory syncytial virus

    The United States of America, as represented by the Department of Health and Human Services · Granted May 13, 2008 · Expires May 8, 2028

    granted
  16. US 7371225

    Method for convection enhanced delivery of therapeutic agents

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 13, 2008 · Expires May 8, 2028

    granted
  17. US 7371572

    Mouse titers after two immunizations with VLPs alone

    The United States of America, as represented by the Department of Health and Human Services · Granted May 13, 2008 · Expires May 8, 2028

    granted
  18. US 7371385

    Method of treating immune pathologies with low dose estrogen

    Government of the United states of America dba The Department of Veterans Affairs · Granted May 13, 2008 · Expires May 8, 2028

    granted
  19. US 7368114

    Fusion protein including of CD4

    The United States of America, as represented by the Department of Health and Human Services · Granted May 6, 2008 · Expires May 1, 2028

    granted
  20. US 7368110

    Antibodies, including Fv molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use

    The United States of America, as represented by the Department of Health and Human Services · Granted May 6, 2008 · Expires May 1, 2028

    granted
  21. US 7368100

    Backbone-substituted bifunctional DOTA ligands, complexes and compositions thereof, and methods of using same

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted May 6, 2008 · Expires May 1, 2028

    granted
  22. US 7368116

    Method of enhancing a targeted immune response against tumors

    The United States of America, as represented by the Department of Health and Human Services · Granted May 6, 2008 · Expires May 1, 2028

    granted
  23. US 7368106

    Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state

    The United States of America, as represented by the Department of Health and Human Services · Granted May 6, 2008 · Expires May 1, 2028

    granted
  24. US 7364719

    Vasoregulating compounds and methods of their use

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 29, 2008 · Expires Apr 24, 2028

    granted